Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

RxSight Sees FY23 Revenue $78M-$83M Vs $76.7M Est

2023 Guidance Highlights Provided 2023 revenue guidance range of $78.0 million to $83.0 million, representing implied growth of 59% to 69% compared to

2023 Guidance Highlights

  • Provided 2023 revenue guidance range of $78.0 million to $83.0 million, representing implied growth of 59% to 69% compared to 2022.
  • Provided 2023 gross margin guidance range of 52% to 54%, representing an implied increase of 19% to 24% compared to 2022.
    • Provided operating expense guidance range of $105.0 million to $108.0 million, representing an implied growth of 24% to 28% compared to 2022.
Total
0
Shares